Quince Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $36 | $0 |
Gross Profit | -44 | -40 | ||
EBITDA | -5,863 | -8,798 | -8,633 | |
EBIT | -5,949 | -8,842 | -8,673 | |
Net Income | -5,492 | -27,729 | -11,149 | -8,894 |
Net Change In Cash | 0 | 0 | 36 | 0 |
Free Cash Flow | -7,306 | -8,778 | -8,392 | -6,102 |
Cash | 2,675 | 7,890 | 21,813 | 20,752 |
Basic Shares | 43,164 | 43,096 | 43,010 | 42,973 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -322 | -175 | -344 | -332 |
EBITDA | -31,260 | -52,015 | -89,974 | -78,561 |
EBIT | -31,582 | -52,190 | -90,318 | -78,893 |
Net Income | -31,385 | -51,660 | -89,325 | -76,849 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -25,329 | |||
Free Cash Flow | -18,452 | -44,171 | -63,112 | -50,870 |
Cash | 20,752 | 44,579 | 69,724 | 66,841 |
Basic Shares | 37,237 | 33,496 | 29,718 | 29,176 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.12 |
2024-06-30 | -$0.64 |
2024-03-31 | -$0.21 |
2023-12-31 | -$0.22 |
